Last updated: 14.12.2017
Aarno Palotie, M.D., Ph.D. is the research director of the Human Genomics program at FIMM. He is also a faculty member at the Center for Human Genome Research at the Massachusetts General Hospital in Boston and associate member of the Broad Institute of MIT and Harvard. He has a long track record in human disease genetics. He has hold professorships and group leader positions at the University of Helsinki, UCLA, Wellcome Trust Sanger Institute, The Broad Institute of MIT and Harvard and the Massachusetts general hospital. He has also been the director of the Finnish Genome Center and Laboratory of Molecular Genetics in the Helsinki University Hospital. He has served in numerous national and international boards, including the FIMM board. He has also chaired several large international research consortia and as a member or chair in national and international expert panels, including the International Headache Genetics Consoritum (IHGC) and the SISu (Sequencing Initiative Suomi) consortium that combines all genome or exome wide sequence data produced from Finnish samples. Aarno Palotie has extensive experience in establishing, running and overseeing infrastructures both in research and clinical settings. In addition to running clinical laboratories and the Finnish Genome Center, he served as the director of Medical Sequencing and a member of the sequencing committee in the Sanger Institute, established and run the tissue array unit in UCLA and has been a key player in planning the National Genome Strategy and national biobanking strategies in Finland. He has published over 400 original publications, reviews and book chapters.